Correlation Between Enlivex Therapeutics and Amylyx Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Enlivex Therapeutics and Amylyx Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enlivex Therapeutics and Amylyx Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enlivex Therapeutics and Amylyx Pharmaceuticals, you can compare the effects of market volatilities on Enlivex Therapeutics and Amylyx Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enlivex Therapeutics with a short position of Amylyx Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enlivex Therapeutics and Amylyx Pharmaceuticals.
Diversification Opportunities for Enlivex Therapeutics and Amylyx Pharmaceuticals
-0.44 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Enlivex and Amylyx is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Enlivex Therapeutics and Amylyx Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amylyx Pharmaceuticals and Enlivex Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enlivex Therapeutics are associated (or correlated) with Amylyx Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amylyx Pharmaceuticals has no effect on the direction of Enlivex Therapeutics i.e., Enlivex Therapeutics and Amylyx Pharmaceuticals go up and down completely randomly.
Pair Corralation between Enlivex Therapeutics and Amylyx Pharmaceuticals
Given the investment horizon of 90 days Enlivex Therapeutics is expected to generate 0.97 times more return on investment than Amylyx Pharmaceuticals. However, Enlivex Therapeutics is 1.03 times less risky than Amylyx Pharmaceuticals. It trades about 0.02 of its potential returns per unit of risk. Amylyx Pharmaceuticals is currently generating about 0.01 per unit of risk. If you would invest 171.00 in Enlivex Therapeutics on September 2, 2024 and sell it today you would lose (57.00) from holding Enlivex Therapeutics or give up 33.33% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enlivex Therapeutics vs. Amylyx Pharmaceuticals
Performance |
| Timeline |
| Enlivex Therapeutics |
| Amylyx Pharmaceuticals |
Enlivex Therapeutics and Amylyx Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enlivex Therapeutics and Amylyx Pharmaceuticals
The main advantage of trading using opposite Enlivex Therapeutics and Amylyx Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enlivex Therapeutics position performs unexpectedly, Amylyx Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amylyx Pharmaceuticals will offset losses from the drop in Amylyx Pharmaceuticals' long position.| Enlivex Therapeutics vs. Scully Royalty | Enlivex Therapeutics vs. Donnelley Financial Solutions | Enlivex Therapeutics vs. Heritage Global | Enlivex Therapeutics vs. Oppenheimer Holdings |
| Amylyx Pharmaceuticals vs. Agilent Technologies | Amylyx Pharmaceuticals vs. Equillium | Amylyx Pharmaceuticals vs. 23Andme Holding Co | Amylyx Pharmaceuticals vs. DiaMedica Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |